Skip Nav Destination
Treatment of Philadelphia chromosome–positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate
Randomized comparison of low-dose versus high-dose interferon-alfa in chronic myeloid leukemia: prospective collaboration of 3 joint trials by the MRC and HOVON groups
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly × 4 schedule
Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study
Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura
X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival
Utilization of Ig heavy chain variable, diversity, and joining gene segments in children with B-lineage acute lymphoblastic leukemia: implications for the mechanisms of VDJ recombination and for pathogenesis
Atypical features of familial hemophagocytic lymphohistiocytosis
Use of B cell–bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders
Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters
Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease
Issue Archive
June 15 2004
Table of Contents
INSIDE BLOOD
PERSPECTIVES
ERRATA
REVIEW IN TRANSLATIONAL HEMATOLOGY
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Treatment of Philadelphia chromosome–positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate
Clinical Trials & Observations
Deborah A. Thomas,Stefan Faderl,Jorge Cortes,Susan O'Brien,Francis J. Giles,Steven M. Kornblau,Guillermo Garcia-Manero,Michael J. Keating,Michael Andreeff,Sima Jeha,Miloslav Beran,Srdan Verstovsek,Sherry Pierce,Laurie Letvak,August Salvado,Richard Champlin,Moshe Talpaz,Hagop Kantarjian
Randomized comparison of low-dose versus high-dose interferon-alfa in chronic myeloid leukemia: prospective collaboration of 3 joint trials by the MRC and HOVON groups
Clinical Trials & Observations
Hanneke C. Kluin-Nelemans,Georgina Buck,Saskia le Cessie,Sue Richards,H. Berna Beverloo,J. H. Frederik Falkenburg,Tim Littlewood,Petra Muus,David Bareford,Hans van der Lelie,Anthony R. Green,Klaas J. Roozendaal,Alison E. Milne,Claire S. Chapman,Patricia Shepherd,for the UK CML Working Group of NCRI and the HOVON trials group
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly × 4 schedule
Clinical Trials & Observations
Michele Ghielmini,Shu-Fang Hsu Schmitz,Sergio B. Cogliatti,Gabriella Pichert,Jörg Hummerjohann,Ursula Waltzer,Martin F. Fey,Daniel C. Betticher,Giovanni Martinelli,Fedro Peccatori,Urs Hess,Emanuele Zucca,Roger Stupp,Tibor Kovacsovics,Claudine Helg,Andreas Lohri,Mario Bargetzi,Daniel Vorobiof,Thomas Cerny,for the Swiss Group for Clinical Cancer Research (SAKK)
Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study
Clinical Trials & Observations
Brief Report
Leo I. Gordon,Arturo Molina,Thomas Witzig,Christos Emmanouilides,Andrew Raubtischek,Mohamed Darif,Russell J. Schilder,Greg Wiseman,Christine A. White
GENE THERAPY
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura
Clinical Trials & Observations
Brief Report
Fabrizio Fabris,Raffaella Scandellari,Elisabetta Ruzzon,Maria Luigia Randi,Guido Luzzatto,Antonio Girolami
IMMUNOBIOLOGY
X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival
Clinical Trials & Observations
Ryuta Nishikomori,Hiroshi Akutagawa,Kyoko Maruyama,Mami Nakata-Hizume,Katsuyuki Ohmori,Kazunori Mizuno,Akihiro Yachie,Takahiro Yasumi,Takashi Kusunoki,Toshio Heike,Tatsutoshi Nakahata
Utilization of Ig heavy chain variable, diversity, and joining gene segments in children with B-lineage acute lymphoblastic leukemia: implications for the mechanisms of VDJ recombination and for pathogenesis
Clinical Trials & Observations
Aihong Li,Montse Rue,Jianbiao Zhou,Hongjun Wang,Meredith A. Goldwasser,Donna Neuberg,Virginia Dalton,David Zuckerman,Cheryl Lyons,Lewis B. Silverman,Stephen E. Sallan,John G. Gribben,for the Dana-Farber Cancer Institute ALL Consortium
Atypical features of familial hemophagocytic lymphohistiocytosis
Clinical Trials & Observations
Brief Report
Rosanna Busiello,Marsilio Adriani,Franco Locatelli,Mario Galgani,Giorgia Fimiani,Rita Clementi,Matilde Valeria Ursini,Luigi Racioppi,Claudio Pignata
Use of B cell–bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen
Brief Report
Philip Savage,Liquan Gao,Kevin Vento,Pam Cowburn,Stephen Man,Neil Steven,Graham Ogg,Andrew McMichael,Agamemnon Epenetos,Els Goulmy,Hans J. Stauss
NEOPLASIA
T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance
Richard L. Piekarz,Robert W. Robey,Zhirong Zhan,Ganesh Kayastha,Anousheh Sayah,Amina H. Abdeldaim,Sonia Torrico,Susan E. Bates
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders
Clinical Trials & Observations
Marco Ladetto,Mara Compagno,Irene Ricca,Marco Pagano,Alberto Rocci,Monica Astolfi,Daniela Drandi,Paola Francia di Celle,Maria Dell'Aquila,Barbara Mantoan,Sonia Vallet,Gloria Pagliano,Federica De Marco,Roberto Francese,Loredana Santo,Alessandra Cuttica,Carlo Marinone,Mario Boccadoro,Corrado Tarella
Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia
Clinical Trials & Observations
Brief Report
Mohamad Mohty,Eric Jourdan,Naira Ben Mami,Norbert Vey,Ghandi Damaj,Didier Blaise,Daniel Isnardon,Daniel Olive,Béatrice Gaugler
RED CELLS
TRANSPLANTATION
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters
Clinical Trials & Observations
Maha El-Zimaity,Rima Saliba,Kawah Chan,Munir Shahjahan,Antonio Carrasco,Ola Khorshid,Humberto Caldera,Daniel Couriel,Sergio Giralt,Issa Khouri,Cindy Ippoliti,Richard Champlin,Marcos de Lima
Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease
Clinical Trials & Observations
Brief Report
Marjan Ertault-Daneshpouy,Christophe Leboeuf,Marc Lemann,Fatiha Bouhidel,Lionel Ades,Eliane Gluckman,Gérard Socié,Anne Janin
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals